Signa Vitae. 2022; 18(3): 158-162. doi: 10.22514/sv.2021.092
Case Report

Brain damage caused by chlorfenapyr poisoning: a case report and literature review

Fanglan Yao1, Dandan Fan1,*,

1Department of Emergency, the First Affiliated Hospital of Xi'an Jiaotong University, 710061 Xi’an, Shaanxi, China

*Corresponding Author(s):fandandan7689@163.com (Dandan Fan)

History Submitted: 09 March 2021 | Accepted: 06 April 2021 | Published: 08 May 2022
Copyright:  ©2022  The Author(s). Published by MRE Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).

Collapse table of contents

Abstract

Chlorfenapyr poisoning is uncommon, but fatal, and is often ignored. Chlorfenapyr inhibits ATP production in the mitochondrial of lipid-rich organs such as the brain. The initial symptoms of chlorfenapyr poisoning are not serious and are usually ignored; fever and unconsciousness are the main signs. Patients often die of brain damage, and survivors often present toxic leukoencephalopathy. We report a case of a 15-year-old female who swallowed 10 mL of 10% chlorfenapyr, and was subjected to gastric lavage one hour after ingestion. The patient felt no discomfort on the first and second day after lavage and went to school. On the third day, the patient complained of a headache and rested at home. On the fourth day, the patient still complained of headache, and the condition progressed to confusion and fever; therefore, the patient was admitted to the emergency room and underwent hemoperfusion. Cerebral CT revealed diffuse brain edema. The patient died on the fourth day because of central fever, brain hernia, and brain dysfunction. Chlorfenapyr poisoning is fatal, even in small doses. Patients suspected of chlorfenapyr poisoning should be closely observed and promptly treated by hemoperfusion.

Keywords:Poisoning;Chlorfenapyr;Leukoencephalopathy;Hemoperfusion
PDF(298.71 KB)|EndNote (RIS)|BibTeX|RefMan|RefWorks

Cite this article

Fanglan Yao, Dandan Fan. Brain damage caused by chlorfenapyr poisoning: a case report and literature review. Signa Vitae. 2022; 18(3): 158-162. doi: 10.22514/sv.2021.092

1. Introduction

Chlorfenapyr is widely used as a pesticide to eliminate cotton worms, insects, and mites [1]. It is highly lipophilic, and its mechanism of action involves the uncoupling of oxidative phosphorylation and respiration in mitochondria, thus preventing ATP production [2]. This leads to anoxic necrosis of cells [2] in lipid-rich organs and other organs that require a high supply of ATP such as the brain, heart, and muscle. We report a case of a 15-year-old female who swallowed chlorfenapyr and died of brain damage and hernia.

2. Case report

A 15-year-old female student presented to our emergency room with a headache and confusion due to the ingestion of 10 mL of 10% chlorfenapyr four days previously, after a quarrel with her mother. The patient bought chlorfenapyr on the internet to kill mites on a dog. She had no history of other diseases.

One hour after chlorfenapyr ingestion, the patient was subjected to gastric lavage, and was placed under observation for approximately 12 hours before being discharged. The next day, the patient did not report any discomfort and went to school. On the third day, she complained of headache and weakness and rested at home.

On the fourth day, the headache did not improve and the patient demonstrated altered levels of consciousness. Therefore, the patient was admitted to the emergency department of our hospital.

The patient was diagnosed with chlorfenapyr poisoning based on the information provided in the anamnesis, and brain damage and symptoms of headache and confusion. The toxicological serum analysis to evaluate toxic agents were not conducted for practical reasons. The vital signs when the patient arrived at the emergency room were as follows: temperature, 36.0 ℃; pulse rate, 95 beats/min; respiratory rate, 23 breaths/min; blood pressure, 116/83 mmHg; and oxygen saturation, 97% in room air. The only physical sign was confusion. The results of the initial arterial blood gas analysis, blood cell analysis, indices of liver and kidney function, coagulation cascade, procalcitonin, myocardial enzymes, troponin T, NT-pro brain natriuretic peptide, and electrolytes are presented in Table 1. The electrocardiogram and the chest CT were normal. Cerebral CT revealed diffuse edema in both hemispheres (Fig. 1).

Table 1.The investigations conducted after admission.
ItemsOn admission11 hours later14 hours laterNormal range
Arterial blood gas value
PH7.4677.4556.8837.35–7.45
PO2 (mmHg)139524480–105
PCO2 (mmHg)32.730.69835–45
HCO3-(mmol/L)23.1211822–27
Lactate (mmol/L)0.952.11>the high limit0.5–1.7
Blood cell analysis value
WBC × 109/L6.238.935–12
NEUT%7790.740–75
LYMPH%15.88.420–50
Blood biochemical value
AST (U/L)1413–45
ALT (U/L)177–40
BUN (mmol/L)4.172.6–7.5
CREA (μmol/L)4241–73
CK (U/L)6640–200
PCT (ng/mL)0.030–0.5
NT-proBNP (pg/mL)87.260–125
hs-TNT (ng/mL)<0.0030–0.014
Na (mmol/L)140.2137–147
K (mmol/L)3.863.5–5.3
CL (mmol/L)108.496–108
Coagulation
PT (s)14.911–14
APTT (s)35.228–43.5
TT (s)14.814–21
Abbreviations: WBC, white blood cell; AST, asparate transaminase; ALT, alanine transaminase; BUN, blood urea nitrogen; CREA, creatinine; CK, creatine Kinase; PCT, procalcitonin; hs-TNT, hypersensitivity troponin T; NT-proBNP, NT-pro brain natriuretic peptide; PT, prothrombin time; APTT, activated partial thromboplastin time; TT, thrombin time.
Cerebral CT showed diffuse edema in both hemispheres.

Fig. 1.Cerebral CT showed diffuse edema in both hemispheres.

Hemoperfusion (HP) was conducted using two resin perfusion columns as soon as the patient arrived at the emergency room. Mannitol and vitamin B were administered and the patient was adequately rehydrated via the intravenous route. Eleven hours later, the patient progressed to light coma, with a high fever of 39.9 ℃; pulse rate, 117 beats/min; respiratory rate, 33 breaths/min; blood pressure, 107/54 mmHg; and oxygen saturation, 84% with an oxygen mask. The arterial blood gas analysis revealed that hypoxia, hyperventilation, metabolic acidosis, and lactic acid value increased. Fourteen hours later, the patient’s breathing became laborious and she progressed to moderate coma; therefore, endotracheal intubation and mechanical ventilation were conducted. The arterial blood gas analysis revealed severe acidosis and hypoxia, CO2 retention, and type Ⅱ respiratory failure, and that the lactate concentration exceeded the highest acceptable limit (Table 1). Fifteen hours later, the heart rate dropped rapidly, eventually leading to cardiac arrest; cardiopulmonary resuscitation (CPR) was immediately but unsuccessfully employed. After 50 minutes of CPR, the patient died. The autopsy was not performed because her father refused.

3. Discussion

In the case reported here, the patient felt no discomfort on the first and second day. Thereafter, the patient complained of headache and weakness on the third day and progressed to altered levels of consciousness on the fourth day. Although HP was conducted, the patient experienced high fever, coma, and laborious respiration, and she died on the fourth day. As we did not find any source of infection or signs of organ failure, and the brain edema was notable on CT, we speculated that she died of central fever and brain hernia and dysfunction.

We searched articles using “chlorfenapyr” and “case” as keywords in titles and abstracts in PubMed, EMBASE, Google Scholar, and Scopus databases from 01/01/1970 to 03/01/2021 and found 12 case reports with full text (Table 2) (Ref. [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14]).

Table 2.The characteristics of the 12 cases of chlorfenapyr poisoning.
Author_YearCountryAge (year)GenderWay of poisoningDosage (mL)Gastric lavageFever (Da)Disorde of consciousness (Db)Blood purification (Dc)Outcome (Dd)Sequelae
Ku JE _2015 [3]Korea61femaleoral10yesyes (d2)yes (1 h)nolivepancreatitis
Baek BH_2016 [4]Korea44femaleoral (spat it out without swallowing)10nonononoliveleukoencephalopathy
Chomin J _2018 [5]America42maleoral300noyes (d6)noHD (d6)death (d6)-
Choi UT _2010 [6]Korea55maleoral250yesyes (d2)yes (d5)HD (d4)death (d5)-
Luo ZH_2020 [7]China66maleoral20yesyes (d2)yes (d4)CRRT + HP (d3)death (d6)-
Tharaknath VR _2013 [8]India28femaleoralnot mentionedyesyes (d10)yes (d10)nodeath (d10)-
Kang C _2014 [9]Korea41femaleoral20noyes (d14)yes (d14)nodeath (d15)-
Lee J _2013 [10]Korea74maleintraabdominal injection20nonononodeath (d12)-
Han S-K _2018 [11]Korea49maledermal exposurenot mentionednoyes (d5)yes (d5)nodeath (d5)-
Kim IS _2018 [12]Korea52maleoral100not mentionedyes (d12)yes (d12)HP (d5, d8)liveleukoencephalopathy
Kim JH _2020 [13]Korea71maleoral100not mentionednononodeath (d20)-
Park SJ _2018 [14]Korea44femaleoral20yesnononolivetoxic optic neuropathy
Abbreviations: Da, first day with fever after poisoning; Db, first day of experiencing confusion after poisoning; Dc, day of blood purification after poisoning; Dd, day of death after poisoning; HD, hemodialysis; CRRT, continuous renal replacement treatment; HP, hemoperfusion.

The results of the literature search are summarized below.

A 61-year-old-female [3] swallowed 10 mL of chlorfenapyr and survived with chronic pancreatitis. A 44-year-old-female [4] progressed to irreversible paralysis because of ingestion of 10 mL of chlorfenapyr, but spat it out without swallowing. The MRI image displayed toxic leukoencephalopathy in white matter tracts throughout the brain, brain stem, and spinal cord. The woman survived probably because she did not swallow the pesticide. A 52-year-old-male [12] swallowed 100 mL of chlorfenapyr, but survived probably because HP was conducted on the fifth and eighth days. The sequela was leukoencephalopathy. A 44-year-old-female [14] swallowed 20 mL of chlorfenapyr and survived with toxic optic neuropathy.

The patients who swallowed 300 mL [5] or 250 mL [6] of chlorfenapyr died despite hemodialysis (HD) probably owing to the excessive intake. A 71-year-old-male [13] swallowed 100 mL of chlorfenapyr and died because of the excessive intake. A 66-year-old-male [7] ingested 20 mL of chlorfenapyr and died despite continuous renal replacement treatment (CRRT) and HP. A 28-year-old-female [8] died, but the exact intake was unknown. A 41-year-old-female [9] ingested 20 mL of chlorfenapyr and died probably due to brain damage. A 74-year-old-male [10] died after an intra-abdominal injection of 20 mL of chlorfenapyr. A 49-year-old-male [11] died after dermal exposure to chlorfenapyr.

From Table 2, we observe that patients with low intake of chlorfenapyr, no fever, and absence of altered consciousness may survive, although they may have sequelae, such as leukoencephalopathy. HP probably clears the poison from the blood, thereby saving the patients’ lives. The lethal dose of chlorfenapyr is low and even skin contact may be lethal [11]. Most of the patients died because of the large intake of the poison. Fever and altered consciousness always indicate brain damage; doctors should be alert because those patients are more likely to die within few days. The death latency of chlorfenapyr poisoning is 7–20 days [3].

In this case, the patient might have had toxic leukoencephalopathy when admitted to the emergency room on the fourth day after poison intake, and we did not have the opportunity to perform a brain MRI. Chlorfenapyr may damage brain areas rich in nerve fibers, such as white matter, leading to toxic leukoencephalopathy [15].

Unlike the patients described in the above reports, the patient described in this report was young. The initial poisoning symptoms are not serious and are usually ignored; fever and unconsciousness are signs that one should be careful about; the patient needs to be observed closely. The limitation of the study is the lack of determination of drug concentration and effective treatment method for Chlorfenapyr poisoning. Chlorfenapyr is lipophilic; therefore, HP may be performed with resin to eliminate it from the body [16], but CRRT has little effect [17]. If the patient survives, hyperbaric oxygen therapy may be implemented to avoid leukoencephalopathy. We should raise awareness among doctors and the young population regarding chlorfenapyr poisoning and inform the population through the internet about its potential harm; children need to be educated not to drink unknown liquids. If chlorfenapyr poisoning is suspected, immediate observation and treatment should be implemented.

Author contributions

FY read and sorted out the relevant literature, and collected the medical records. DF designed the research and wrote the whole article, and revised it. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Ethical approval was obtained from the Ethics Committee of the First Affiliated Hospital of Medical College of Xi’an Jiaotong University (XJTU1AF2021LSK-057).

Acknowledgment

The authors acknowledge the institutional support from the First Affiliated Hospital of Xi’an Jiaotong University; Thank numerous individuals participated in this study; I would like to express my gratitude to all those who helped me during the writing of this manuscript; Thanks to all the peer reviewers for their opinions and suggestions.

Funding

This research received no external funding.

Conflict of interest

The authors declare no conflict of interest.

References

Herron GA, Rophail J, Wilson LJ. Chlorfenapyr resistance in two-spotted spider mite (Acari: Tetranychidae) from Australian cotton. Experimental and Applied Acarology. 2004; 34: 315–321.

[Google Scholar]

Periasamy S, Deng J, Liu M. Who is the real killer? Chlorfenapyr or detergent micelle-chlorfenapyr complex? Xenobiotica. 2017; 47: 833–835.

[Google Scholar]

Ku JE, Joo YS, You JS, Chung SP, Lee HS. A case of survival after chlorfenapyr intoxication with acute pancreatitis. Clinical and Experimental Emergency Medicine. 2015; 2: 63–66.

[Google Scholar]

Baek BH, Kim SK, Yoon W, Heo TW, Lee YY, Kang HK. Chlorfenapyr-induced toxic leukoencephalopathy with radiologic reversibility: a case report and literature review. Korean Journal of Radiology. 2016; 17: 277–280.

[Google Scholar]

Chomin J, Heuser W, Nogar J, Ramnarine M, Stripp R, Sud P. Delayed hyperthermia from chlorfenapyr overdose. The American Journal of Emergency Medicine. 2018; 36: 2129.e1–2129.e2.

[Google Scholar]

Choi UT, Kang GH, Jang YS, Ahn HC, Seo JY, Sohn YD. Fatality from acute chlorfenapyr poisoning. Clinical Toxicology. 2010; 48: 458–459.

[Google Scholar]

Luo ZH, Chen YQ, Lin JR, Jiang WZ. A case report of death from acute emamectin·chlorfenapyr poisoning. Chinese Journal of Industrial Hygiene and Occupational Diseases. 2020; 38: 534–535.

[Google Scholar]

Tharaknath VR, Prabhakar YVS, Kumar KS, Babu NK. Clinical and radiological findings in chlorfenapyr poisoning. Annals of Indian Academy of Neurology. 2013; 16: 252–254.

[Google Scholar]

Kang C, Kim DH, Kim SC, Kim DS. A patient fatality following the ingestion of a small amount of chlorfenapyr. Journal of Emergencies, Trauma, and Shock. 2014; 7: 239–241.

[Google Scholar]

Lee J, Lee JH, Baek JM, Lee DS, Park IY, Won JM, et al. Toxicity from intra-abdominal injection of chlorfenapyr. Case Reports in Emergency Medicine. 2013; 2013: 425179.

[Google Scholar]

Han S, Yeom S, Lee S, Park S, Kim H, Cho Y, et al. A fatal case of chlorfenapyr poisoning following dermal exposure. Hong Kong Journal of Emergency Medicine. 2019; 26: 375–378.

[Google Scholar]

Kim IS, Kim JH, Kim JB, Kim JH. Chlorfenapyr intoxication manifested by extensive leukoencephalomyelopathy. Journal of the Korean Neurological Association. 2018; 36: 390–392.

[Google Scholar]

Kim JH, Park NH, Park JY, Kim S. Magnetic resonance imaging and clinical features of chlorfenapyr-induced toxic leukoencephalopathy: a case report. Journal of the Korean Society of Radiology. 2020; 81: 985–989.

[Google Scholar]

Park SJ, Jung JU, Kang YK, Chun BY, Son BJ. Toxic optic neuropathy caused by chlorfenapyr poisoning. Journal of the Korean Ophthalmological Society. 2018; 59: 1097–1102.

[Google Scholar]

Kumar Y, Drumsta D, Mangla M, Gupta N, Hooda K, Almast J, et al. Toxins in brain! Magnetic resonance (MR) imaging of toxic leukoencephalopathy—a pictorial essay. Polish Journal of Radiology. 2017; 82: 311–319.

[Google Scholar]

Ghannoum M, Bouchard J, Nolin TD, Ouellet G, Roberts DM. Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance, and application in clinical practice. Seminars in Dialysis. 2014; 27: 350–361.

[Google Scholar]

Kade G, Spaleniak S, Antosiewicz S. Continuous renal replacement therapy as a treatment of selected acute intoxications. Polski Merkuriusz Lekarski. 2020; 49: 250–254.

[Google Scholar]